These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30078832)

  • 1. Genetic Variations, Triglycerides, and Atherosclerotic Disease.
    Tada H; Kawashiri MA
    J Atheroscler Thromb; 2019 Feb; 26(2):128-131. PubMed ID: 30078832
    [No Abstract]   [Full Text] [Related]  

  • 2. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies.
    Dib I; Khalil A; Chouaib R; El-Makhour Y; Noureddine H
    Mol Biol Rep; 2021 Jan; 48(1):875-886. PubMed ID: 33389539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [THE ETIOLOGY AND PATHOGENESIS OF SUCCESSIVE MAKING TEST ON HYPERTRIGLYCERIDEMIA, HYPERCHOLESTEROLEMIIA AND HYPOGLYCEMIA. THE COMMON CHARACTER OF ETIOLOGIC FACTORS OF METABOLIC PANDEMIC AND COMPENSATORY ROLE OF APOC-111].
    Titov VN
    Klin Lab Diagn; 2016 Jan; 61(1):4-12. PubMed ID: 27183722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism.
    Luo M; Peng D
    Lipids Health Dis; 2016 Oct; 15(1):184. PubMed ID: 27770802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridemia and atherosclerosis.
    Peng J; Luo F; Ruan G; Peng R; Li X
    Lipids Health Dis; 2017 Dec; 16(1):233. PubMed ID: 29212549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes and Consequences of Hypertriglyceridemia.
    Packard CJ; Boren J; Taskinen MR
    Front Endocrinol (Lausanne); 2020; 11():252. PubMed ID: 32477261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.
    Cefalù AB; Noto D; Arpi ML; Yin F; Spina R; Hilden H; Barbagallo CM; Carroccio A; Tarugi P; Squatrito S; Vigneri R; Taskinen MR; Péterfy M; Averna MR
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4584-90. PubMed ID: 19820022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia.
    Gouni-Berthold I
    Atheroscler Suppl; 2017 Nov; 30():19-27. PubMed ID: 29096837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies.
    Tada H; Nohara A; Kawashiri MA
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient.
    Liu Y; Xu J; Tao W; Yu R; Zhang X
    J Atheroscler Thromb; 2019 Feb; 26(2):136-144. PubMed ID: 29910226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia.
    Dai Perrard XY; Lian Z; Bobotas G; Dicklin MR; Maki KC; Wu H
    J Clin Lipidol; 2017; 11(6):1361-1371. PubMed ID: 28942094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of triglycerides in atherosclerosis.
    Talayero BG; Sacks FM
    Curr Cardiol Rep; 2011 Dec; 13(6):544-52. PubMed ID: 21968696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
    Rosenson RS; Davidson MH; Hirsh BJ; Kathiresan S; Gaudet D
    J Am Coll Cardiol; 2014 Dec; 64(23):2525-40. PubMed ID: 25500239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
    Toth PP
    Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
    Luo M; Su X; Yi Y; Yang Y; Peng D
    Lipids Health Dis; 2018 Jul; 17(1):160. PubMed ID: 30021607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic basis of primary hypertriglyceridemia].
    Gotoda T
    Nihon Rinsho; 2013 Sep; 71(9):1558-64. PubMed ID: 24205714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia.
    Mitsuguchi Y; Ito T; Ohwada K
    Comp Med; 2008 Oct; 58(5):465-80. PubMed ID: 19004373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.
    Goldberg IJ
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):700-706. PubMed ID: 29419410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical science relating atherosclerotic diseases and hypertriglyceridemia].
    Fujioka Y
    Nihon Rinsho; 2013 Sep; 71(9):1546-51. PubMed ID: 24205712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.